Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
C144
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
C102
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
C105
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
Iv0205
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Neutralization
Human
Monoclonal
IgA
S309
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Neutralization
Human
Monoclonal
IgM
S309
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Neutralization
Human
Monoclonal
IgG1, kappa
1H1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Neutralization
Human
Monoclonal
IgG1, kappa
5E1#
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
FCM, Neutralization, SPR
Human
Monoclonal
IgG1, kappa
2E6#
Human coronavirus HKU1 (HCoV-HKU1), Human coronavirus OC43 (HCoV-OC43), Middle East respiratory syndrome-related coronavirus (MERS-CoV), Severe acute respiratory syndrome coronavirus (SARS-CoV), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Neutralization
Human
Monoclonal
IgG1, kappa
S2P6